|
| Status |
Public on Aug 12, 2021 |
| Title |
Subtype Heterogeneity and Epigenetic Convergence in Neuroendocrine Prostate Cancer [ATAC-seq] |
| Organism |
Homo sapiens |
| Experiment type |
Genome binding/occupancy profiling by high throughput sequencing
|
| Summary |
We analyzed chromatin accessibility, ChIP-seq and RNA-seq across neuroendocrine carcinomas from distinct anatomic origins including Merkel cell carcinomas, neuroendocrine prostate cancer, small cell lung cancer and gastrointestinal NECs.
|
| |
|
| Overall design |
ATAC-seq analysis of PDXs and clinical tissues.
|
| |
|
| Contributor(s) |
Long H |
| Citation(s) |
34599169 |
| |
| Submission date |
Aug 14, 2020 |
| Last update date |
Apr 06, 2023 |
| Contact name |
Yingtian Xie |
| E-mail(s) |
yingtian_xie@dfci.harvard.edu
|
| Organization name |
DANA FARBER CANCER INSTITUTE INC
|
| Street address |
450 BROOKLINE AVE
|
| City |
Boston |
| State/province |
MA |
| ZIP/Postal code |
02215 |
| Country |
USA |
| |
|
| Platforms (1) |
| GPL18573 |
Illumina NextSeq 500 (Homo sapiens) |
|
| Samples (27)
|
|
| This SubSeries is part of SuperSeries: |
| GSE156292 |
Subtype Heterogeneity and Epigenetic Convergence in Neuroendocrine Prostate Cancer |
|
| Relations |
| BioProject |
PRJNA657289 |
| SRA |
SRP277569 |
Less...
More...